Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Systematic Review

The association between C-reactive protein and coronary artery calcification: a systematic review and meta-analysis

Authors: Amirhossein Tajani, Masoumeh Sadeghi, Navid Omidkhoda, Amir Hooshang Mohammadpour, Sara Samadi, Vahid Jomehzadeh

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

While coronary artery calcification (CAC) is recognized as a reliable marker for coronary atherosclerosis, the relationship between the concentration of C-reactive protein (CRP) and the incidence and progression of CAC remains controversial.

Method

PubMed, Embase, Web of Science, and Scopus were systematically searched to identify relevant observational studies until October 2023. The methodological quality of the included studies was evaluated using the Newcastle-Ottawa Scale (NOS). A random-effects meta-analysis was employed to calculate pooled odd ratios (OR) and corresponding 95% confidence intervals, considering heterogeneity among the studies.

Results

Out of the 2545 records, 42 cross-sectional and 9 cohort studies were included in the systematic review. The meta-analysis on 12 eligible cross-sectional studies revealed no significant association between CAC and CRP [pooled OR: 1.03 (1.00, 1.06)]. Additionally, an insignificant association was found between CAC and CRP through meta-analysis on three eligible cohort studies [pooled OR: 1.05 (0.95, 1.15)] with no considerable heterogeneity across studies. Sensitivity analyses indicated that the meta-analysis models were robust. There was no evidence of publication bias.

Conclusion

Based on the meta-analysis findings, elevated levels of CRP did not emerge as a valuable prognostic maker for CAC incidence and progression prediction.
Appendix
Available only for authorised users
Literature
1.
Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639.PubMedCrossRef
2.
Eun Y, Lee SN, Song SW, Kim HN, Kim SH, Lee YA, et al. Fat-to-muscle ratio: a New Indicator for Coronary Artery Disease in healthy adults. Int J Med Sci. 2021;18(16):3738–43.PubMedPubMedCentralCrossRef
3.
Lee H, Park HE, Yoon JW, Choi SY. Clinical significance of body fat distribution in coronary artery calcification progression in Korean population. Diabetes Metabolism J. 2021;45(2):219–30.CrossRef
4.
Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23(6):3346.PubMedPubMedCentralCrossRef
5.
Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003;108(17):2054–9.PubMedCrossRef
6.
Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105(5):546–9.PubMedCrossRef
7.
8.
Gerhardt T, Ley K. Monocyte trafficking across the vessel wall. Cardiovascular Res. 2015;107(3):321–30.CrossRef
9.
Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103(2):181.PubMedPubMedCentral
10.
11.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363–9.PubMedCrossRef
12.
Calabró P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108(16):1930–2.PubMedCrossRef
13.
Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30:261–77.PubMedCrossRef
14.
Zhang D, Sun M, Samols D, Kushner I. STAT3 participates in Transcriptional activation of the C-reactive protein gene by Interleukin-6 (∗). J Biol Chem. 1996;271(16):9503–9.PubMedCrossRef
15.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.PubMedCrossRef
16.
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56(25):e50–103.PubMedCrossRef
17.
18.
19.
Panh L, Lairez O, Ruidavets J-B, Galinier M, Carrié D, Ferrières J. Coronary artery calcification: from crystal to plaque rupture. Arch Cardiovasc Dis. 2017;110(10):550–61.PubMedCrossRef
20.
Mark DB, Berman DS, Budoff MJ, Carr JJ, Gerber TC, Hecht HS, ACCF/ACR/AHA/NASCI/SAIP/SCAI, et al. SCCT 2010 Expert Consensus Document on Coronary computed Tomographic Angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus documents. J Am Coll Cardiol. 2010;55(23):2663–99.PubMedCrossRef
21.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.PubMedCrossRef
22.
New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circul Res. 2013;113(1):72–7.CrossRef
23.
Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368:2004–13.PubMedCrossRef
24.
Kageyama A, Matsui H, Ohta M, Sambuichi K, Kawano H, Notsu T, et al. Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-κB, novel targets of Eicosapentaenoic Acid. PLoS ONE. 2013;8(6):e68197.PubMedPubMedCentralCrossRef
25.
Oh J, Park S, Yu HT, Chang HJ, Lee SH, Kang SM, Choi D. Lack of superiority for Soluble ST2 over high sensitive C-Reactive protein in Predicting High Risk Coronary Artery Calcium score in a community cohort. Yonsei Med J. 2016;57(6):1347–53.PubMedPubMedCentralCrossRef
26.
Zeb I, Jorgensen NW, Blumenthal RS, Burke GL, Lloyd-Jones D, Blaha MJ, et al. Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2021;339:27–34.PubMedCrossRef
27.
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. In: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
28.
Lukito AA, Bakri S, Kabo P, Wijaya A. The mechanism of coronary artery calcification in centrally obese non-diabetic men: study on the interaction of leptin, free leptin index, adiponectin, hs-C reactive protein, bone morphogenetic protein-2 and matrix Gla Protein. Mol Cell Biomedical Sci. 2020;4(2):88–93.CrossRef
29.
Kimani C, Kadota A, Miura K, Fujiyoshi A, Zaid M, Kadowaki S, et al. Differences between coronary artery calcification and aortic artery calcification in relation to cardiovascular disease risk factors in Japanese men. J Atheroscler Thromb. 2019;26(5):452–64.PubMedPubMedCentralCrossRef
30.
Nagasawa SY, Ohkubo T, Masaki K, Barinas-Mitchell E, Miura K, Seto TB, et al. Associations between inflammatory markers and subclinical atherosclerosis in middle-aged white, Japanese-American and Japanese men: the ERA-JUMP study. J Atheroscler Thromb. 2015;22(6):590–8.PubMedCrossRef
31.
Zhang ZY, Bian LQ, Kim SJ, Zhou CC, Choi YH. Inverse Relation of Total Serum Bilirubin to coronary artery calcification score detected by Multidetector computed tomography in males. Clin Cardiol. 2012;35(5):301–6.PubMedPubMedCentralCrossRef
32.
Zhang Z, Bian L, Choi Y. Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. Angiology. 2012;63(6):420–8.PubMedCrossRef
33.
Wang NC, Matthews KA, Barinas-Mitchell EJM, Chang CCH, El Khoudary SR. Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and white race/ethnicity: the study of women’s Health across the Nation (SWAN) heart study. Menopause-the J North Am Menopause Soc. 2016;23(6):653–61.CrossRef
34.
Nandkeolyar S, Naqvi A, Fan W, Sharma A, Rana JS, Rozanski A, et al. Utility of novel serum biomarkers to predict subclinical atherosclerosis: a sub-analysis of the EISNER study. Atherosclerosis. 2019;282:80–4.PubMedCrossRef
35.
Diederichsen SZ, Grønhøj MH, Mickley H, Gerke O, Steffensen FH, Lambrechtsen J, et al. CT-Detected growth of coronary artery calcification in asymptomatic middle-aged subjects and Association with 15 biomarkers. JACC Cardiovasc Imaging. 2017;10(8):858–66.PubMedCrossRef
36.
Gauss S, Klinghammer L, Steinhoff A, Raaz-Schrauder D, Marwan M, Achenbach S, Garlichs CD. Association of systemic inflammation with epicardial fat and coronary artery calcification. Inflamm Res. 2015;64(5):313–9.PubMedCrossRef
37.
Okwuosa TM, Greenland P, Burke GL, Eng J, Cushman M, Michos ED, et al. Prediction of coronary artery calcium progression in individuals with low Framingham risk score: the multi-ethnic study of atherosclerosis. JACC: Cardiovasc Imaging. 2012;5(2):144–53.PubMed
38.
Hamer M, Endrighi R, Venuraju SM, Lahiri A, Steptoe A. Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women. PLoS One. 2012;7(2):e31356.PubMedPubMedCentralCrossRef
39.
Taylor AJ, Bindeman J, Le TP, Bauer K, Byrd C, Feuerstein IM, et al. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness. Atherosclerosis. 2008;197(1):339–45.PubMedCrossRef
40.
Wu YJ, Mar GY, Wu MT, Wu FZ. A LASSO-Derived risk model for subclinical CAC progression in Asian Population with an initial score of Zero. Front Cardiovasc Med. 2021;7:619798.PubMedPubMedCentralCrossRef
41.
Sajjadieh A, Arefpour A. Evaluation of the relation between serum level of high-sensitivity reactive protein (Hs-CRP) and coronary calcification with the presence of coronary artery disease in computed tomography angiography. J Isfahan Med School. 2019;37(351):673–9.
42.
Fu K, Liu H-D, MaMuTi K, Hu D-N, Hao P. Relationship between carbohydrate antigen 125 and coronary artery calcification in patients without known coronary artery disease. Med Sci Monitor: Int Med J Experimental Clin Res. 2018;24:2873.CrossRef
43.
Hughes-Austin JM, Wassel CL, Jiménez J, Criqui MH, Ix JH, Rasmussen-Torvik LJ, et al. The relationship between adiposity-associated inflammation and coronary artery and abdominal aortic calcium differs by strata of central adiposity: the multi-ethnic study of atherosclerosis (MESA). Vasc Med. 2014;19(4):264–71.PubMedPubMedCentralCrossRef
44.
Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women - the Framingham heart study. Circulation. 2002;106(10):1189–91.PubMedCrossRef
45.
Sung KC, Cho EJ, Lim YH, Shin J, Pyun WB, Kang SM, Rosenson RS. HDL-C levels modify the association between C-reactive protein and coronary artery calcium score. Nutr Metab Cardiovasc Dis. 2014;24(11):1240–5.PubMedCrossRef
46.
Quaglia LA, Freitas WM, Soares AA, Santos RD, Nadruz W, Blaha M, et al. C-reactive protein is independently associated with coronary atherosclerosis burden among octogenarians. Aging Clin Exp Res. 2014;26:19–23.PubMedCrossRef
47.
Qasim AN, Budharaju V, Mehta NN, St Clair C, Farouk S, Braunstein S, et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol (Oxf). 2011;74(1):44–50.PubMedCrossRef
48.
Okwuosa TM, Greenland P, Lakoski SG, Ning H, Kang J, Blumenthal RS, et al. Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2011;107(6):879–85.PubMedPubMedCentralCrossRef
49.
Freitas WM, Quaglia LA, Santos SN, Soares AAS, Japiassu AVT, Boaventura V, et al. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly. Atherosclerosis. 2011;216(1):212–6.PubMedCrossRef
50.
Cederström S, Lundman P, Alfredsson J, Hagström E, Ravn-Fischer A, Söderberg S, et al. Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population. Sci Rep. 2023;13(1):12171.PubMedPubMedCentralCrossRef
51.
Erdöl MA, Gayretli Yayla K. Relationship between C-reactive protein to albumin ratio and coronary artery calcium score and CAD-RADS scores with coronary computed tomography angiography. Turk J Med Sci. 2021;51:2674–82.PubMedPubMedCentralCrossRef
52.
Arps K, Rifai MA, Blaha MJ, Michos ED, Nasir K, Yeboah J, et al. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for Atherothrombotic Cardiovascular events to consider low-dose Rivaroxaban Thromboprophylaxis (from MESA). Am J Cardiol. 2019;124(8):1198–206.PubMedPubMedCentralCrossRef
53.
Harada PH, Benseñor IM, Bittencourt MS, Nasir K, Blaha MJ, Jones SR, et al. Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Cardiol. 2019;73(5):408–15.PubMedCrossRef
54.
Mehta A, Patel J, Al Rifai M, Ayers CR, Neeland IJ, Kanaya AM, et al. Inflammation and coronary artery calcification in South asians: the mediators of atherosclerosis in South asians living in America (MASALA) study. Atherosclerosis. 2018;270:49–56.PubMedPubMedCentralCrossRef
55.
Pesaro AE, Katz M, Liberman M, Pereira C, Mangueira CLP, de Carvalho AEZ, et al. Circulating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction. PLoS ONE. 2018;13(8):e0202738.PubMedPubMedCentralCrossRef
56.
Wang Y, Zhou BY, Zhu CG, Guo YL, Wu NQ, Qing P, et al. Distribution of ABO blood groups and coronary artery calcium. Heart Lung Circ. 2017;26(6):593–8.PubMedCrossRef
57.
Kaplan H, Thompson RC, Trumble BC, Wann LS, Allam AH, Beheim B, et al. Coronary atherosclerosis in indigenous south American tsimane: a cross-sectional cohort study. Lancet. 2017;389(10080):1730–9.PubMedPubMedCentralCrossRef
58.
Kim BJ, Kang JG, Lee SH, Lee JY, Sung KC, Kim BS, Kang JH. Relationship of echocardiographic Epicardial Fat Thickness and Epicardial Fat volume by computed tomography with coronary artery calcification: data from the CAESAR Study. Arch Med Res. 2017;48(4):352–9.PubMedCrossRef
59.
Kommuri NV, Zalawadiya SK, Veeranna V, Kollepara SLS, Ramesh K, Briasoulis A, Afonso L. Association between various anthropometric measures of obesity and markers of subclinical atherosclerosis. Expert Rev Cardiovasc Ther. 2016;14(1):127–35.PubMedCrossRef
60.
Yu K, Min X, Lin Y, Huang Y, Huang S, Liu L, et al. Increased IL-37 concentrations in patients with arterial calcification. Clin Chim Acta. 2016;461:19–24.PubMedCrossRef
61.
Wu GY, Xu BD, Wu T, Wang XY, Wang TX, Zhang X, et al. Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure. Biomedical Rep. 2016;5(5):601–6.CrossRef
62.
Sorensen MH, Gerke O, Eugen-Olsen J, Munkholm H, Lambrechtsen J, Sand NPR, et al. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects. Atherosclerosis. 2014;237(1):60–6.PubMedCrossRef
63.
Navaravong L, Steenson C, Sigurdsson G. Coronary plaque type and burden by computed tomography angiography without association to C-reactive protein. North Am J Med Sci. 2014;6(6):21–6.CrossRef
64.
Rhee EJ, Seo MH, Kim JD, Jeon WS, Park SE, Park CY, et al. Metabolic health is more closely associated with coronary artery calcification than obesity. PLoS ONE. 2013;8(9):e74564.PubMedPubMedCentralCrossRef
65.
Tanaka M, Fukui M, Tomiyasu K, Akabame S, Nakano K, Yamasaki M, et al. Eosinophil count is positively correlated with coronary artery calcification. Hypertens Res. 2012;35(3):325–8.PubMedCrossRef
66.
Atar AI, Yilmaz OC, Akin K, Selcoki Y, Er O, Eryonucu B. Association between gamma-glutamyltransferase and coronary artery calcification. Int J Cardiol. 2013;167(4):1264–7.PubMedCrossRef
67.
Bian L-Q, Zhang Z-Y, Kim S-J, Zhou C-C, Choi Y-H. Gamma glutamyltransferase as a novel marker of coronary artery calcification in women. J Cardiovasc Med. 2012;13(11):684–90.CrossRef
68.
Raaz-Schrauder D, Klinghammer L, Baum C, Frank T, Lewczuk P, Achenbach S, et al. Association of systemic inflammation markers with the presence and extent of coronary artery calcification. Cytokine. 2012;57(2):251–7.PubMedCrossRef
69.
Jenny NS, Brown ER, Detrano R, Folsom AR, Saad MF, Shea S, et al. Associations of inflammatory markers with coronary artery calcification: results from the multi-ethnic study of atherosclerosis. Atherosclerosis. 2010;209(1):226–9.PubMedCrossRef
70.
Ramadan MM, Mahfouz EM, Gomaa GF, El-Diasty TA, Alldawi L, Ikrar T, et al. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ J. 2008;72(5):778–85.PubMedCrossRef
71.
Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113(1):38–43.PubMedCrossRef
72.
Huang PH, Chen LC, Leu HB, Ding PY, Chen JW, Wu TC, Lin SJ. Enhanced coronary calcification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest. 2005;128(2):810–5.PubMedCrossRef
73.
Kullo IJ, McConnell JP, Bailey KR, Kardia SL, Bielak LF, Peyser PA, et al. Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension. Am J Cardiol. 2003;92(1):56–8.PubMedCrossRef
74.
Reilly MP, Wolfe ML, Localio AR, Rader DJ. C-reactive protein and coronary artery calcification: the study of inherited risk of coronary atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol. 2003;23(10):1851–6.PubMedCrossRef
75.
Vazirian F, Sadeghi M, Wang D, Javidi Dashtbayaz R, Gholoobi A, Samadi S, Mohammadpour AH. Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies. BMC Cardiovasc Disord. 2023;23(1):1–10.CrossRef
76.
Vazirian F, Sadeghi M, Kelesidis T, Budoff MJ, Zandi Z, Samadi S, Mohammadpour AH. Predictive value of lipoprotein (a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2023;33(11):2055–2066.
77.
Abedi F, Sadeghi M, Omidkhoda N, Kelesidis T, Ramezani J, Samadi S, Mohammadpour AH. HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):1–16.CrossRef
78.
Samadi S, Sadeghi M, Dashtbayaz RJ, Nezamdoost S, Mohammadpour AH, Jomehzadeh V. Prognostic role of osteoprotegerin and risk of coronary artery calcification: a systematic review and meta-analysis. Biomark Med. 2022;17(3):171–80.CrossRef
79.
Mohammadpour AH, Shamsara J, Nazemi S, Ghadirzadeh S, Shahsavand S, Ramezani M. Evaluation of RANKL/OPG serum concentration ratio as a new biomarker for coronary artery calcification: a pilot study. Thrombosis. 2012;2012:306263.PubMedPubMedCentralCrossRef
80.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. Circulation. 2014;129(25suppl2):S1–45.PubMed
81.
Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303(16):1610–6.PubMedPubMedCentralCrossRef
82.
Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.PubMedCrossRef
83.
Kavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi A-A, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016;316(20):2126–34.PubMedCrossRef
84.
Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401–8.PubMedPubMedCentralCrossRef
85.
Aguiar FJ, Ferreira-Júnior M, Sales MM, Cruz-Neto LM, Fonseca LA, Sumita NM, et al. Proteína C reativa: aplicações clínicas e propostas para utilização racional. Rev Assoc Méd Bras. 2013;59(1):85–92.PubMedCrossRef
86.
da Silva SH, Moresco RN. Biomarcadores cardíacos na avaliação da síndrome coronariana aguda. Scientia Med. 2011;21(3):132–142.
87.
Du Clos TW, Mold C. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors. Curr Opin Organ Transplant. 2011;16(1):15.PubMedPubMedCentralCrossRef
88.
Pitthan E, Martins OMO, Barbisan JN. Novos biomarcadores inflamatórios E De disfunção Endotelial: predição de risco cardiovascular. Rev AMRIGS. 2014;58(1):69–77.
89.
Rader DJ. Inflammatory markers of coronary risk. N Engl J Med; 2000; 19;343(16)1179–82.
90.
Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148(1):S19–26.PubMedCrossRef
91.
Abdelbaky A, Corsini E, Figueroa AL, Fontanez S, Subramanian S, Ferencik M, et al. Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study. Circ Cardiovasc Imaging. 2013;6(5):747–54.PubMedCrossRef
92.
Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E–deficient mice. Circulation. 2004;109(5):647–55.PubMedCrossRef
93.
Tennent GA, Hutchinson WL, Kahan MC, Hirschfield GM, Gallimore JR, Lewin J, et al. Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE–/– mice. Atherosclerosis. 2008;196(1):248–55.PubMedCrossRef
Metadata
Title
The association between C-reactive protein and coronary artery calcification: a systematic review and meta-analysis
Authors
Amirhossein Tajani
Masoumeh Sadeghi
Navid Omidkhoda
Amir Hooshang Mohammadpour
Sara Samadi
Vahid Jomehzadeh
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03856-5

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue

Research

Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study

Systematic Review

Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention: a meta-analysis of cohort studies

Research

The effect of exercise training intervention for patients with abdominal aortic aneurysm on cardiovascular and cardiorespiratory variables: an updated meta-analysis of randomized controlled trials

Research

Changes in patient profiles in the cardiology department of the University Hospital Gabriel Touré (UH-GT) : results of two cross-sectional studies of 2010 and 2022

Research

Early and mid-term outcomes of open thoracoabdominal aortic aneurysm repair after thoracic endovascular aortic repair

Research

In emergency hypertension, could biomarkers change the guidelines?